Tunisian Association of Pharmacology Holds Third Scientific Congress
The Tunisian Association of Pharmacology organized its third scientific congress today, Friday, October 31, 2025, under the theme of "Systems for Managing and Reimbursing Medication Expenses." In a statement to National Radio, the Minister of Health, Mustapha Ferjani, indicated that Tunisia is one of the first Arab and African countries to enter the pharmaceutical manufacturing market, specifying that it produces 70% of its medication needs. Ferjani considered this percentage to be very important, adding that the goal is to achieve pharmaceutical sovereignty. He emphasized that today's congress is working towards achieving this sovereignty and developing the pharmaceutical industry, particularly with the existence of a biotechnology factory project. The minister explained that Tunisia has the necessary skills and is capable, in cooperation with certain countries like South Korea and others, of establishing an industry in the field of biotechnology. He highlighted that one of the most important recommendations to emerge from the congress is the publication of therapeutic protocols for this purpose. Mustapha Ferjani mentioned that a national authority will be created to ensure fairness in access to medications. Additionally, the Minister of Health stated that a draft law aimed at regulating the dietary supplement sector is one of the ministry's priorities. He revealed that this draft law will be introduced before the end of 2025. It will define the terms of use for dietary supplements and their promotion mechanisms, in collaboration and partnership with doctors, pharmacists, and the Tunisian Medicines Agency, with the goal of organizing the sector. For his part, the President of the Tunisian Association of Pharmacology, Dr. Riadh Daghfous, discussed the main points of the congress. He indicated that numerous experiences in the field of pharmacology will be examined, specifying that the rapid evolution of medications worldwide requires Tunisia to keep pace by improving its capabilities, with the goal of ensuring the availability of medications.
